ITI Life Sciences signs commercialisation licence agreements with Edinburgh Instruments and Almac Sciences (Scotland) Ltd

01-Mar-2007 - ITI Life Sciences announced the signing of two Commercialisation Licence agreements based on intellectual assets created during ITI Life Sciences' Fluorescence Lifetime Assay Programme, using fluorescence lifetime for 3-D cell-based assays and other applications. The first licence, signed with ...

Tecan Opens New Application Development Center in Kobe, Japan

29-Sep-2004 - Männedorf, Switzerland. Tecan, a leading player in the Life Sciences supply industry, officially opens its new Application Development Center in Japan on 1st October 2004. The facility will support the protocol development needs of customers in Japan and East Asia. In addition, the center will be ...

PerkinElmer And BioImage Announce Collaboration For Cell-Based Screening Applications

26-Aug-2004 - Boston, Mass and Copenhagen, Demark. PerkinElmer Inc. announced plans to collaborate with BioImage to develop cell-based assays on the PerkinElmer EnVision(tm) HTS multilabel plate reader platform. The commercial terms of the collaboration were not disclosed. Based in Denmark, BioImage is a ...

GE Healthcare Announces Licensing Agreements with Bristol-Myers Squibb and Regeneron Pharmaceuticals for Green Fluorescent Prote

Access to GFP technology aids drug discovery and development

11-Jun-2004 - Chalfont St. Giles, UK: GE Healthcare, a combination of the former Amersham and GE Medical Systems, today announced that Bristol-Myers Squibb and Regeneron Pharmaceuticals have each signed licensing agreements for rights to Aequorea Victoria Green Fluorescent Protein (AvGFP), the most versatile, ...

PerkinElmer Launches the SmartStation Integrated Platform and Five New Drug Discovery Offerings

Products to be Showcased at the Conference for the Society for Biomolecular Screening (SBS)

25-Sep-2002 - BOSTON, Sep 23, 2002 -- PerkinElmer, a leading provider of drug discovery, life science research and genetic disease screening solutions, will showcase its new SmartStation(TM) Integrated Platform and five additional drug discovery solutions at the Conference for the Society for Biomolecular ...

PerkinElmer Life Sciences Announces a Fully Automated Workstation for Nucleic Acid Normalization

07-Aug-2002 - BOSTON Aug. 5, 2002 - PerkinElmer Life Sciences, today announced availability of a new integrated workstation for automated, high-throughput normalization of nucleic acid samples. Normalization is a technique that standardizes sample concentration to improve the quality of downstream ...